Continental Advisors’s NxStage Medical Inc. NXTM Stock Holding History

Continental Advisors’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-44,763	Closed	-$1.12M	–	136
2017 Q2	$1.12M	Sell	44,763 -15,000	-25%	-$371K	0.25%	95
2017 Q1	$1.6M	Sell	59,763 -30,000	-33%	-$829K	0.36%	76
2016 Q4	$2.35M	Sell	89,763 -19,801	-18%	-$490K	0.64%	51
2016 Q3	$2.74M	Sell	109,564 -10,000	-8%	-$233K	0.76%	47
2016 Q2	$2.59M	Hold	119,564	–	–	0.8%	46
2016 Q1	$1.79M	Hold	119,564	–	–	0.51%	58
2015 Q4	$2.62M	Sell	119,564 -10,000	-8%	-$186K	0.67%	50
2015 Q3	$2.04M	Hold	129,564	–	–	0.55%	61
2015 Q2	$1.85M	Sell	129,564 -8,500	-6%	-$144K	0.49%	68
2015 Q1	$2.39M	Hold	138,064	–	–	0.53%	66
2014 Q4	$2.48M	Hold	138,064	–	–	0.5%	63
2014 Q3	$1.81M	Hold	138,064	–	–	0.41%	70
2014 Q2	$1.98M	Hold	138,064	–	–	0.46%	65
2014 Q1	$1.76M	Sell	138,064 -13,000	-9%	-$170K	0.45%	62
2013 Q4	$1.51M	Buy	151,064 +60,100	+66%	+$682K	0.33%	83
2013 Q3	$1.2M	Hold	90,964	–	–	0.3%	86
2013 Q2	$1.3M	Buy	+90,964	New	+$1.14M	0.37%	78

Other funds holding NXTM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Continental Advisors's NXTM Position: Q3 2017 in Review

Continental Advisors sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 44,763 shares — an estimated $1.12M sold.

Continental Advisors first reported a position in NXTM in Q2 2013 and held it in 17 quarters. The position peaked at $2.74M in Q3 2016. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

Continental Advisors reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
Continental Advisors sold 44,763 NxStage Medical Inc. shares in Q3 2017, an estimated $1.12M.
Continental Advisors first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 17 quarters.
Continental Advisors's NxStage Medical Inc. position peaked at $2.74M in Q3 2016.
168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Continental Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.